Bone marrow transplantation is still the only potential option of a cure for hematological tumors Published on 23/02/2023 Bone marrow donation, which may improve the patient's prognosis, does not pose any health risk for the donor nor does it require admission to the operating room
MD Anderson Cancer Center Madrid – Hospiten launches a new Haematopoietic Transplant Unit Published on 27/02/2020 After more than 15 years of experience in autologous and allogeneic transplants, MD Anderson Cancer Madrid has launched a new Haematopoietic Transplant Unit with a view to enhancing and developing the transplant programme and offering CAR-T therapy.